Donoghue Forlines’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-8,598
Closed -$474K 88
2019
Q4
$474K Sell
8,598
-1,638
-16% -$88.9K 0.07% 140
2019
Q3
$515K Sell
10,236
-3,242
-24% -$163K 0.07% 140
2019
Q2
$679K Sell
13,478
-7,829
-37% -$380K 0.08% 123
2019
Q1
$990K Buy
+21,307
New +$1.08M 0.1% 106
2018
Q4
Sell
-15,750
Closed -$977K 66
2018
Q3
$977K Buy
15,750
+6,581
+72% +$400K 0.08% 141
2018
Q2
$494K Sell
9,169
-3,460
-27% -$173K 0.04% 109
2018
Q1
$574K Buy
+12,629
New +$541K 0.05% 108

Other funds holding EHC

Donoghue Forlines's EHC Position: Q1 2020 in Review

Donoghue Forlines sold out of Encompass Health (EHC) in Q1 2020, closing a stake of 8,598 shares — an estimated $474K sold.

Donoghue Forlines first reported a position in EHC in Q1 2018 and held it in 7 quarters. The position peaked at $990K in Q1 2019. 374 funds tracked by Wall St. Rank hold EHC as of Q1 2020.

  • Donoghue Forlines reported no remaining Encompass Health position as of Q1 2020 after selling out during the quarter.
  • Donoghue Forlines sold 8,598 Encompass Health shares in Q1 2020, an estimated $474K.
  • Donoghue Forlines first reported a position in Encompass Health in Q1 2018 and held it in 7 quarters.
  • Donoghue Forlines's Encompass Health position peaked at $990K in Q1 2019.
  • 374 funds tracked by Wall St. Rank held Encompass Health as of Q1 2020.

Based on Donoghue Forlines's 13F filing for Q1 2020, filed 12 May 2020.